Nika Pharmaceuticals, Inc
NIKA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001145604
No open-market purchases or sales by Nika Pharmaceuticals, Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Nika Pharmaceuticals, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Nika Pharmaceuticals, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Savov Dimitar Slavchev | CEO, CFO, President | 455,589,500 | Mar 19, 2025 | 0 |
| Nika Pharmaceuticals, Inc | Secretary | 5,000,000Indirect | Mar 19, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 (view filing)3:31 PM ET | Mar 18 | 1 day | Savov Dimitar SlavchevCEO, CFO, President | SSale | −2.00M | $0.25 | −$500.0K | −0.4%455.6M after | |
| Mar 19, 2024 (view filing)2:08 PM ET | Apr 13, 2022 | 706 daysLate | Nika Pharmaceuticals, IncPresident, CEO, CFO | PPurchaseCommon | +11.5M | $0.012 | +$137.9K | – | |
| Mar 19, 2024 (view filing)2:08 PM ET | Sep 12, 2022-Jun 2, 2023 | 554 daysLate | Nika Pharmaceuticals, IncPresident, CEO, CFO | SSaleCommon | −22.6M | $0.0182 | −$410.0K | – | 6 lots |